Amino acid sequences directed against HER2 and polypeptides comprising the same for the treatment of cancers and/ or tumors

Details for Australian Patent Application No. 2008328779 (hide)

Owner Ablynx N.V.

Inventors Revets, Hilde; Hoogenboom, Hendricus Renerus Jacobus Matteus; Boutton, Carlo

Agent Shelston IP

Pub. Number AU-A-2008328779

PCT Pub. Number WO2009/068625

Priority 61/004,332 27.11.07 US; 61/005,324 04.12.07 US; 61/005,265 04.12.07 US; 61/005,331 04.12.07 US

Filing date 27 November 2008

Wipo publication date 4 June 2009

International Classifications

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/32 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

Event Publications

10 June 2010 PCT application entered the National Phase

  PCT publication WO2009/068625 Priority application(s): WO2009/068625

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008328781-Amino acid sequences directed against heterodimeric cytokines and/or their receptors and polypeptides comprising the same

2008328776-Compositions intended to increase piglet appetite